Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

Background. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 Canadian patients with Clostridium difficile infection (CDI), based on data from 2 randomized, clinical trials. Methods. Patients received fidaxomicin or vancomycin 1. Patients were assessed for clinical response...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Christine, Louie, Thomas J., Weiss, Karl, Valiquette, Louis, Gerson, Marvin, Arnott, Wendy, Gorbach, Sherwood L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904592/
https://www.ncbi.nlm.nih.gov/pubmed/27366179
http://dx.doi.org/10.1155/2016/8048757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904592/
https://www.ncbi.nlm.nih.gov/pubmed/27366179
http://dx.doi.org/10.1155/2016/8048757

Ejemplares similares